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1. Introduction 
Hypertension is a common condition, a risk factor for heart disease, renal failure and stroke, 
affecting approximately 1 billion individuals worldwide and 200 million in China[1, 2]. Thus, 
understanding the underlying etiology of hypertension has been a major research focus, 
especially the genetics of essential hypertension (EH), large proportion of hypertension. 
Indeed, since the completion of the draft sequence of human genome, geneticists have 
announced that within 10 years they expect to determine the significance of the genome as 
related to essential hypertension[3]. Some progress has been made. For example, for systolic 
blood pressure alone, 27 nuclear loci have been identified in populations of European and 
African ancestry[3]. However, to date no consistent results have been obtained across 
ethnicity and races supporting the need for genetic studies in diverse populations [4-8]. 
While the nuclear genome has been studied extensively with respect to hypertension, much 
less work has been done with the mitochondrial genome (mtDNA). Yet there is evidence to 
suggest that mitochondria and mtDNA may be important in hypertension. For example, 
mitochondria produce reactive oxidative species (ROS) and these ROS can cause 
hypertension [9-11]. With respect to the evidence of mtDNA, a hallmark of involvement of 
mtDNA is maternal inheritance. Multiple studies have identified strong maternal 
inheritance of blood pressure, with one study suggesting that over one-third of 
hypertension could be attributed to mtDNA variation [12-14]. Interestingly, a variant in 
mitochondrial tRNAIle has been identified in a single family which segregated with 
hypertension and appeared causal [15]. Taken together, this work suggests the importance of 
looking at mtDNA variation to further our understanding of the underlying etiology of EH.  
2. Mitochondria 
2.1 Biogenesis and bioenergetics 
Matrilineal inheritance in EH pedigrees support the hypothesis that mitochondrial genes are 
also implicated in the pathogenesis of EH. Mitochondria evolved from protobacteria that 
inhabited primordial eukaryotic cells about 1.5 billion years ago and were first observed 
more than100 years ago by Altmann. It’s a small symbiotic (0.5-1μm) organelle combined 
with aerobic bacteria and primordial eukaryotic cells. 37 genes make up a mitochondrion 
within which thousands of mtDNA forming double-stranded 16569 base-pair.(Fig. 1) Of 
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these genes, 24 encode RNAs necessary for protein synthesis (22 tRNAs and 2 rRNAs), The 
remaining 13 genes encode proteins that are critical subunits of the respiratory chain. 
 
 
 
Fig. 1. Human mitochondrial DNA (mtDNA) map showing location of selected pathogenic 
mutations associated with left ventricular hypertrophy or hypertrophic cardiomyopathy. 
Human mtDNA is a 16569 base pair circular molecule that codes for 7(ND1,2,3,4,4L,5 and 6) 
of 43 subunits of complex I; 1 (cytochrome b) of 11 subunits of complex III; 3 (COI, II and III) 
of 13 subunits of complex IV; and 2( ATPase 6 and 8) of 16 subunits of complex V. It also 
codes for small and large rRNAs and 22tRNAs, with adjacent letters indicating cognate 
amino acids. (Adapted from Hirano M et al. Mitochondria and the heart. Current Opinion in 
Cardiology 2001, 16:201–210.) 
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The mitochondrion contains an inner and an outer membrane which defines the matrix 
and the intermembrane space. The outer membrane is permeable to small molecules (up 
to 10 kDa ) whereas the inner membrane is freely permeable to oxygen and carbon 
dioxide. This relative impermeability of the inner membrane is essential for maintaining a 
proton gradient necessary for the synthesis of adenosine triphosphate (ATP). There are 
several unique features of mtDNA and mitochondrial genetics which are distinct from the 
features of nuclear genes and the principles of nuclear inheritance. First, mammalian 
mtDNA does not contain introns which make mtDNA mutations affect phenotype of 
diseases much more easily comparing to nuclear genes. Second, several mitochondrial 
genetic codons differ from the universal nuclear genetic code. UCG codes for tryptophan 
and not termination, AUA codes for methionine not isoleucine, and AGA and AGG are 
termination rather than arginine codons. AUA are possibly AUU are initiation codons as 
well as AUG. Third, only the mother contributes to the mtDNA pool of the offspring, It 
dues mostly to the fact to a large extent that sperm contains only 100 mtDNA while egg 
contains approximately 10,000 mtDNA[16]. Fourth, the fixation of mtDNA mutations is 
more than 10 times higher in comparison with the nuclear DNA mutation rate [17]. A 
possible explanation for this difference is the lack of protective histones and the absence 
of effective DNA repair systems within mitochondria. In addition, by being exposed to 
tremendous fluxes of oxygen, mtDNA may also be a target for the reactive oxygen species 
produced as by-products of oxidative phosphorylation. Fifth, an individual may carry 
several allelic forms of mtDNA, present in different proportions in different tissues [18,19]. 
The coexistence of more than one type of mtDNA within a cell, wide-type accompany 
with mutant type, is called heteroplasmy. Sixth, there is as yet no conclusive evidence 
demonstrating that orthodox recombination occurs between individual mtDNA 
molecules. New mtDNA alleles can thus only arise through spontaneous mutations. In 
spite of striking difference of morphological and inherited characteristics from nuclear 
genes, mitochondria have three major functions which associated with pathogenesis of 
diseases synergically. (energetic, reactive oxygen species, apoptosis). First, mitochondria 
offer about 90%-95% energy to cells through oxidative phosphorylation(OXPHOS). Five 
multipolypeptide enzyme complexes make up OXPHOS(Fig.2) as follows.: Complex 
I(NADH:ubiqunone oxidoreductase), II(succinate: uiquinone oxidoreductase), 
III(ubiquinol: ferrocytochrome C oxidoreductase), IV (cytochrome C oxidase) constitute 
electron transport train(ETC).Through ETC, energy is released to pump protons from 
inside the mitochondrial matrix across the mitochondrial inner membrane into the 
intermembrane space . And the electrochemical gradient(△ψ) results from ETC offers 
energy for complex V (H+- translocating ATP synthase) to produce adenosine 
triphosphate.  
Second, toxic by-products, reactive oxygen species(ROS) including O2-, H2O2 and .OH, 
derived from mitochondrial OXPHOS do harm to cells to variable extents according to 
different period of time exposure to ROS. Short-term exposure to ROS can reduce the 
activity of ETC and slow down the metabolism while long-term exposure will induce 
irreversible oxidative damage thus cause markedly reduction of mitochondrial  
function.  
www.intechopen.com
 
Genetics and Pathophysiology of Essential Hypertension 
 
172 
Third, mitochondria are implicated in the initiation of apoptosis in specific circumstances 
through opening mitochondrial permeability transition pore (mtPTP) within the 
membrane. Program cell death activates for the leaking of apoptosis-promoting factors 
located in matrix such as cytochrome c. apoptosis-initiation factor(AIF) and kinds of 
caspases by mtPTP.  
2.2 Mitochondria and heart diseases 
For the three basic functions of mitochondria indicated above, the hypothesis of 
mitochondria participates in pathogenesis of heart diseases have been supported by both 
experimental and clinical evidences. 
In 1988, the first disease-causing mutation of mtDNA were found that patients with 
mitochondrial myopathy identified a variety of functional defects of the mitochondrial 
respiratory chain, predominantly affecting complex I (NADH-CoQ reductase) or complex III 
(ubiquinol–cytochrome c reductase) in adult cases[20, 21].This discovery led to a rapid surge in 
the research into mitochondrial disorders, and there are now more than 200 different 
mtDNA mutations linked to human disease (http://www.mitomap.org) Given the fact that 
heart is a second largest oxygen-consumed organ within body with 12 % oxygen necessary 
to work averagely just less than brain, it follows that heart should be a harrowing victim for 
oxygen deficiency in vivo. Actually, Every heart beat consumes 2% of total cellular ATP. 
And 90% of its ATP is produced by mitochondrial oxidative phosphorylation. Thus, 
mitochondria are assumed to be implicated in the pathogenesis of multiple cardiovascular 
diseases, with regard to the basic functions of the organelle[22]. 
Mitochondria are found to influence all of the four major features of cadiomyocytes: 
excitability, contractility, conductibility and autorhythmicity to certain degree. The rate and 
force of contraction of heart muscle change according to ATP utilization. Patients with 
mtDNA deletions named sporadic rearrangements often develop atrioventricular blocks, 
which progress from mild to severe (type I to type III )[23, 24], respectively. Kearns-Sayre 
Syndrome (KSS) and Chronic Progressive External Ophthalmoplegia(CPEO) are the major 
multisystemic disorders which affect cardiac conductive system particularly. Diversity of 
cardiac conduction defects including prolonged intraventricular conductiontime, bundle-
branch block, and atrioventricular block often lead to sudden cardiac death. 4.9kb 
“common” deletion loci from ATP6 through COIII, ND3, ND4L, ND4, to ND5 contribute to 
KSS[25]. While A3243G mutation associates with maternally inherited PEO with RRF[26] and 
diabetes and deafness[27].Aon MA, et al introduced a novel conception “mitochondrial 
criticality” to describe the state in which the mitochondrial network of cardiomyocytes 
becomes very sensitive to small perturbations in reactive oxygen species (ROS), resulting in 
the scaling of local mitochondrial uncoupling and ΔΨm loss to the whole cell, and the 
myocardial syncytium. The energetic changes are translated into effects on the electrical 
excitability of the cell, inducing temporal heterogeneity of excitability in the heart, underlies 
the genesis of potentially lethal cardiac arrhythmias [28]. 
Except for arrhythmia and excitability, mitochondrial dysfunction has also been suggested 
to reduce contraction of heart thus result in heart failure and age-associated decline in heart 
function [29-32]. 
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Fig. 2. Diagram showing the relationships of mitochondrial oxidative phosphorylation 
(OXPHOS) to (a) energy (ATP) production, (b) reactive oxygen species (ROS) production, 
and (c) initiation of apoptosis through the mitochondrial permeability transition pore 
(mtPTP). The OXPHOS complexes, designated I to V, are complex I (NADH: ubiquinone 
oxidoreductase) encompassing a FMN (flavin mononucleotide) and six Fe-S centers 
(designated with a cube); complex II (succinate: ubiquinone oxidoreductase) involving a 
FAD (flavin adenine dinucleotide), three Fe-S centers, and a cytochrome b; complex III 
(ubiquinol: cytochrome c oxidoreductase) encompassing cytochromes b, c1 and the Rieske 
Fe-S center; complex IV (cytochrome c oxidase) encompassing cytochromes a + a3 and CuA 
and CuB; and complex V (H+-translocating ATP synthase). Pyruvate from glucose enters 
the mitochondria via pyruvate dehydrogenase (PDH), generating acetylCoA, which enters 
the TCA cycle by combining with oxaloacetate (OAA). Cis-aconitase converts citrate to 
isocitrate and contains a 4Fe-4S center. Lactate dehydrogenase (LDH) converts excess 
pyruvate plus NADH to lactate. Small molecules defuse through the outer membrane via 
the voltage-dependent anion channel (VDAC) or porin. The VDAC together with ANT, Bax, 
and the cyclophilin D (CD) protein are thought to come together at the mitochondrial inner 
and outer membrane contact points to create the mtPTP. The mtPTP interacts with the pro-
apoptotic Bax, anti-apoptotic Bcl2 and the benzodiazepine receptor (BD). The opening of the 
mtPTP is associated with the release of several pro-apoptotic proteins. Cytochrome c (cytc) 
interacts with and activates cytosolic Apaf-1, which then binds to and activates procaspase-
9. The activated caspase-9 then initiates the proteolytic degradation of cellular proteins. 
Apoptosis initiating factor (AIF) and endonuclease G (EndoG) have nuclear targeting 
peptides that are transported to the nucleus and degrade the chromosomal DNA. (Adapted 
from Wallance DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482-8.) 
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3. Genetic basis of EH 
3.1 Nuclear genes 
Previous studies of hypertension in humans and experimental animal models have 
identified a number of candidate genes that have been implicated as possibly contributing to 
essential hypertension. The renin-angiotensin-aldosterone system may play a prominent 
role in the genesis of hypertension, and polymorphisms of the genes coding for 
angiotensinogen, angiotensin-converting enzyme, angiotensin II type 1 and 2 receptors, and 
aldosterone synthase have been widely studied. Other mechanisms may involve the KLK 1 
gene of tissue kallikrein, gene variants of endothelial nitric oxide synthase and 
polymorphisms of the endothelin-1 gene. A number of studies have highlighted the 
potential contribution of polymorphisms of genes coding for inflammatory cytokines, 
adrenergic receptors and intracellular G proteins, which can activate Na+/K+ exchangers. 
Multiple researches found that the genetic findings may vary greatly according to the 
populations studied and the causal relationship between candidate genes and EH were 
difficult to establish firmly[33-35]. Further studies found that mitochondrial variants in EH 
were heatedly discussed in late 5 years. 
4. Mitochondrial genes 
4.1 Clinical researches of mtDNA mutation in EH 
Schwartz F, et al[36] investigated the contribution of the mitochondrial genome to 
hypertension and quantitative blood pressure (BP) phenotypes in the Framingham Heart 
Study cohort. Longitudinal BP values of 6421 participants (mean age, 53 years; 46% men) 
from 1593 extended families were analyzed. The role of mitochondrial influence in the 
hypertensives was 35.2% (95% confidence interval, 27-43%, P < 10) The mitochondrial 
heritabilities for multivariable-adjusted long-term average systolic BP and diastolic BP 
were, respectively, 5% (P < 0.02) and 4% (P = 0.11). Schwartz F, et al[37] compared maternal 
and paternal contributions to the familial aggregation of hypertension in 344 hypertensive 
probands.Among them, 69 were African American, 153 US Caucasian, 122 Greek 
Caucasian. It was found that the proportion of hypertensive mothers (81.7, 65.0 and 84.8% 
for African Americans, US Caucasians and Greek Caucasians, respectively) of these 
probands was significantly greater than the proportion of hypertensive fathers (50.0, 44.9 
and 48.3%, respectively) in all three ethnic groups. The lifetime risk of hypertension was 
significantly greater for mothers compared with fathers of these hypertensive probands 
(p<0.001). Examination of the proband's siblings indicated that maternal history of 
hypertension was associated with greater lifetime risk for hypertension than paternal 
history (p<0.01).Thus, it drew the conclusion maternal influence on blood pressure 
suggested involvement of mitochondrial DNA in the pathogenesis of EH. Muscari A, et al 
[38] hypothesized that hypertension is a condition resulted from elevated levels of reactive 
oxygen (ROS) and nitrogen (RNS) species. Mitochondria are important sites of ROS 
production, and a mitochondrial dysfunction, preceding endothelial dysfunction, might 
favor the development of hypertension. ROS production may also be induced by RNS, 
which inhibit the respiratory chain and may be generated through the action of a 
mitochondrial NO synthase. Mitochondrial uncoupling proteins are involved in both 
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experimental and human hypertension. Finally, an excessive production of ROS may 
damage mitochondrial DNA, with resultant impairment in the synthesis of some 
components of the respiratory chain and further ROS production, a vicious cycle that may 
be implicated in hypertensive states. 
5. Our studies of mtDNA mutation in EH 
To determine the relationship between mitochondrial genomic variation and essential 
hypertension, we performed a systematic and extensive screening of mitochondrial genes at 
the Institute of Geriatric Cardiology, Chinese PLA General Hospital in a large Chinese 
cohort. We focused on this Chinese population because of the high morbidity of essential 
hypertension in Chinese adults (nearly 11.8%)2 and the limited amount of research on this 
racial group. We used a population instead of family-based strategy for two reasons: 1) 
Large numbers of hypertensives without family history are not detected in China, and they 
might be overlooked for lacking of medical knowledge and regular checks. 2) The morbidity 
of essential hypertension is not totally family-based; 50-60% of hypertensives are 
sporadically distributed.2  
We sequenced mitochondrial genomes in 306 age and gender balanced Chinese 
hypertensives and controls. In the 153 hypertensives, putative functional changes included 4 
changes in rRNA genes, 11 changes in tRNA genes and 25 amino acid substitutions. The 
remaining variants were synonymous changes or non-coding regions. In the 153 controls, 1 
base change in the tRNA genes and 8 amino acid substitutions were found. A8701G in ATP6 
gene (belongs to haplogroup M) (P=0.0001) and C8414T in ATP8 gene (belongs to 
haplogroup D) (P=0.0001) were detected significantly different in the cases and controls. 
Interestingly, the cases were more likely to have two or more amino acid changes and RNAs 
variants as compared to the controls (24.75% versus 7.94%, P=0.0001). In addition, several 
variants were highly conserved and/or specifically located at the 3’ end adjacent to the 
anticodon, which may contribute to the stabilization of structure thus lead to the decrease of 
tRNA metabolism. In the cohort of hypertensives, there were several variants that occurred 
too infrequently to have sufficient statistical power but that have biologic plausibility. 
T4363C localized at the 3’ end adjacent to the anticodon, which contributed to the 
stabilization of structure thus lead to the decrease of tRNA metabolism. A4263G at the initial 
part of tRNAIle may influence the transcription of tRNA herein affect the steady-level of 
protein synthesis. And some other novel RNAs variants (C3168CC, G3173A, A3203G, 
T3290C, A4263G, T4363C, C4410A, T8311C) in 16s RNA, tRNALeu(UUR), tRNAIle, tRNAMet , 
tRNAGln and tRNALys only found in hypertensives but not controls. In coding regions, even 
though a novel point variant G8720C in ATP6 gene, with high conservation among species 
was not significant in epidemiological perspective. Synergetic interaction between 
mitochondrial mtSNPs and/or haplogroups is needed to be investigated in the future[39]. 
Sequence analysis then performed in tRNA genes, hot spots for cardiovascular diseases, in 
270 Chinese Han essential hypertensives and 270 controls. Lymphoblastoid cell lines were 
immortalized by transformation with the Epstein-Barr virus. Rates of oxygen consumption 
in intact cells were determined with a YSI 5300 oxygraph (Yellow Springs Instruments) on 
samples, harboring variants in tRNA genes. In the study, environmental factors including 
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age, gender, BMI, fasting blood sugar and blood lipids, contributing a lot to high blood 
pressure [40,41] didn’t exhibit difference between cases and controls. It was presumed that 
hereditary factors may associate with the pathogenesis of hypertension in the Chinese 
Han population. There were 26 variants in tRNA genes were found in hypertensives and 
these variants were not in controls. Functional analysis found that these variants may lead 
to deficiencies in tRNA 3’ end metabolism (3’ end cleavage, CCA addition and 
aminoacylation) and/or impairment of critical subunits of the respiratory chain, which 
help understanding of molecular mechanisms of mitochondrial tRNA genes in essential 
hypertension as follows: C3254T and A8348G mildly reduced the efficiency of aminoacyl-
tRNA synthetase (aaRS) [42]; A4295G reduced efficiency of tRNA 3′-processing 
endoribonuclease (tRNAseZ) and aaRS [43]; A4317G reorganized T-stem which markedly 
reduced the efficiency of tRNA 3′-processing endoribonuclease tRNAseZ, aaRS, and tRNA 
nucleotidyl transferase (CCAse) [44]. The other possible effects of tRNA mutations on 
tRNA modifications may be the reduction of efficiency of the binding properties of 
aminoacyl-tRNAs to mitochondrial elongation factor Tu (Ef-Tu) [45]. All of the above 
variants influenced the process of aminoacylation which affected tRNA metabolism and 
impaired the synthesis of protein ultimately. Most importantly, eight of these variants 
were highly conserved from bacteria to human beings (A4263G, A4295G, A4316TA, 
A4343G, A4388G, C4392T, C4410A and A4435G) thus minor changes in charge or 
structure may result in impairment of translation and affect the synthesis of protein. In 
addition, A4295G, A4435G and T4363C all localized at the 3’ end adjacent to the 
anticodon, which contributed to the stabilization of structure thus lead to the decrease of 
tRNA metabolism. Otherwise, a novel variant A4263G at the initial part of tRNAIle may 
influence the transcription of tRNA herein affect the steady-level of protein synthesis. It 
also possible that such mutations could affect the tRNAs correct decoding of the mRNA in 
the ribosome (by increase in frameshifting for example) and, particularly in the case of 
T4363C, could also interfere with aminoacylation, since glutaminyl-tRNA synthetases are 
known to interrogate the anticodon loop of tRNAGln during catalysis [46]. And some other 
novel tRNA variants (T4277C, T4353C, C4410A, T8311C) in tRNALeu(UUR), tRNAIle, 
tRNAMet, tRNAGln and tRNALys need to be further investigated in the future. Interestingly, 
functional analysis found significant reduction of oxygen consumption rate in two mutant 
cell lines carrying variants T4454C and A4263G. Oxygen consumption is a classical means 
of assessing energy expenditure, one component of energy balance [47, 48]. Cells and 
organisms are able to trigger an adaptive response to hypoxic conditions that is aimed to 
help them to cope with these threatening conditions [49]. Failing to keep the balance of 
oxygen consumption and production may cause cardiovascular diseases and is of 
particular significance in the pathogenesis of essential hypertension. A variant in 
mitochondrial tRNAIle has been identified in a single family which segregated with 
hypertension and appeared causal [14]. Interestingly, we deduced that except the A4263G 
and T4454C variants, there were other amino acid changes may contributing to 
hypertension by entire mitochondrial genome sequencing of the cells. This finding would 
suggest that there may be a threshold effect with some of these mtDNA variants. Such 
that often variability at a single locus will not be sufficient to increase hypertension risk. 
This is consistent with previous work that essential hypertension is controlled by multiple 
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genetic loci, each with a relatively weak effect in the population at large [50]. Most 
importantly, the oxygen consumption rate in cells harboring variants T4454C (P=0.0010) 
and A4263G (P=0.0001) decreased as compared to the average level of control cell lines. 
The findings suggested that variants located in mitochondrial tRNA genes may have 
biologic plausibility to implicate in the pathogenesis of Chinese essential hypertension. 
6. Prospects 
The mitochondrial influence in EH remains a lot of questions to be answered. The 
mitochondrial variants always seem to be infrequent and perhaps even private, relationship 
between nuclear genes and mitochondrial genes is obscure, enviromental influence 
somehow affects results of studies of mitochondria. All in all, there’s still a long way to go to 
disclose the secret of mitochondria and EH. 
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